72,684 results on '"neuroblastoma"'
Search Results
52. Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
53. A Study of N9 Chemotherapy in Children with Neuroblastoma
54. Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
55. A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
56. Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
57. Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
58. Methionine PET/CT Studies In Patients With Cancer
59. Neuroblastoma Maintenance Therapy Trial (NMTT)
60. Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
61. A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
62. Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
63. Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
64. Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
65. GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma (GPC2)
66. NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
67. MIBG With Dinutuximab +/- Vorinostat
68. Neuroblastoma Biology Study
69. A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
70. A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory Neuroblastoma (NICE)
71. Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
72. 68Ga-DOTATATE Neuroblastoma Imaging Pilot
73. Pediatric Precision Laboratory Advanced Neuroblastoma Therapy (PEDS-PLAN)
74. B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
75. Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
76. Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
77. Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
78. PediCARE Health Equity Intervention in High-Risk Neuroblastoma
79. Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
80. Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
81. Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
82. Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
83. Trial of Tolcapone With Oxaliplatin for Neuroblastoma
84. Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
85. Molecular-Guided Therapy for Childhood Cancer
86. Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
87. A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
88. Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
89. An Intermediate Expanded Use Trial of DFMO
90. Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
91. TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma
92. Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
93. An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
94. C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
95. 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol
96. Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
97. PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy (PEACH)
98. Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
99. Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma (Aflac-NBL-2002)
100. Identification of New Gene Spliceosomes in Neuroblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.